Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28966
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHuber T.B.en
dc.contributor.authorFranzenburg S.en
dc.contributor.authorKoch-Nolte F.en
dc.contributor.authorTurner J.-E.en
dc.contributor.authorRiedel J.-H.en
dc.contributor.authorHuber S.en
dc.contributor.authorGagliani N.en
dc.contributor.authorWiech T.en
dc.contributor.authorRohde H.en
dc.contributor.authorBono M.R.en
dc.contributor.authorBonn S.en
dc.contributor.authorPanzer U.en
dc.contributor.authorMittrucker H.-W.en
dc.contributor.authorKrebs C.F.en
dc.contributor.authorReimers D.en
dc.contributor.authorZhao Y.en
dc.contributor.authorPaust H.-J.en
dc.contributor.authorBartsch P.en
dc.contributor.authorNunez S.en
dc.contributor.authorRosemblatt M.V.en
dc.contributor.authorHellmig M.en
dc.contributor.authorKilian C.en
dc.contributor.authorBorchers A.en
dc.contributor.authorEnk L.U.B.en
dc.contributor.authorZinke M.en
dc.contributor.authorBecker M.en
dc.contributor.authorSchmid J.en
dc.contributor.authorKlinge S.en
dc.contributor.authorWong M.N.en
dc.contributor.authorPuelles V.G.en
dc.contributor.authorSchmidt C.en
dc.contributor.authorBertram T.en
dc.contributor.authorStumpf N.en
dc.contributor.authorHoxha E.en
dc.contributor.authorMeyer-Schwesinger C.en
dc.contributor.authorLindenmeyer M.T.en
dc.contributor.authorCohen C.D.en
dc.contributor.authorRink M.en
dc.contributor.authorKurts C.en
dc.date.accessioned2021-05-14T09:45:58Zen
dc.date.available2021-05-14T09:45:58Zen
dc.date.copyright2020en
dc.date.created20201124en
dc.date.issued2020-11-24en
dc.identifier.citationScience Immunology. 5 (50) (no pagination), 2020. Article Number: 4163. Date of Publication: August 2020.en
dc.identifier.issn2470-9468 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/28966en
dc.description.abstractAlthough it is well established that microbial infections predispose to autoimmune diseases, the underlying mechanisms remain poorly understood. After infection, tissue-resident memory T (TRM) cells persist in peripheral organs and provide immune protection against reinfection. However, whether TRM cells participate in responses unrelated to the primary infection, such as autoimmune inflammation, is unknown. By using high-dimensional single-cell analysis, we identified CD4+ TRM cells with a TH17 signature (termed TRM17 cells) in kidneys of patients with ANCA-associated glomerulonephritis. Experimental models demonstrated that renal TRM17 cells were induced by pathogens infecting the kidney, such as Staphylococcus aureus, Candida albicans, and uropathogenic Escherichia coli, and persisted after the clearance of infections. Upon induction of experimental glomerulonephritis, these kidney TRM17 cells rapidly responded to local proinflammatory cytokines by producing IL-17A and thereby exacerbate renal pathology. Thus, our data show that pathogen-induced TRM17 cells have a previously unrecognized function in aggravating autoimmune disease.Copyright © 2020 American Association for the Advancement of Science. All rights reserved.en
dc.languageEnglishen
dc.languageenen
dc.publisherAmerican Association for the Advancement of Scienceen
dc.relation.ispartofScience Immunology-
dc.titlePathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1126/SCIIMMUNOL.ABA4163-
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid32769171 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32769171]en
dc.identifier.source2007665836en
dc.identifier.institution(Krebs, Paust, Bartsch, Hellmig, Kilian, Borchers, Enk, Zinke, Riedel, Panzer) III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Krebs, Koch-Nolte, Turner, Huber, Gagliani, Huber, Bonn, Panzer, Mittrucker) Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany (Reimers, Schmid, Klinge, Schmidt, Bertram, Koch-Nolte, Mittrucker) University Medical Center Hamburg-Eppendorf, Institute for Immunology, Hamburg, Germany (Zhao, Bonn) University Medical Center Hamburg-Eppendorf, Institute of Medical Systems Biology, Hamburg, Germany (Nunez) Fundacion Ciencia Vida, SantiagoChile (Rosemblatt, Wiech) Faculty of Medicine and Science, Universidad San Sebastian, Santiago, Chile (Becker, Wong, Puelles, Hoxha, Lindenmeyer, Cohen, Turner, Huber) III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Puelles) Department of Nephrology, And Center for Inflammatory Diseases, Monash University, Monash Health, Melbourne, VIC, Australia (Stumpf, Kurts) Institutes of Molecular Medicine and Experimental Immunology (IMMEI), Rheinische Friedrich-Wilhelms-Universitat, Bonn, Germany (Meyer-Schwesinger) University Medical Center Hamburg-Eppendorf, Institute for Cellular and Integrative Physiology, Hamburg, Germany (Cohen) Nephrological Center, Medical Clinic and Policlinic IV, University of Munich, Munich, Germany (Rink) Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Franzenburg) Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany (Huber, Gagliani) I.Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Gagliani) Department of Medicine, Immunology and Allergy Unit, Karolinska Institute and University Hospital, Solna ,Stockholm 17176, Sweden (Panzer) University Medical Center Hamburg-Eppendorf, Institute for Pathology, Germany (Rohde) University Medical Center Hamburg-Eppendorf, Institute for Medical Microbiology, Virology and Hygiene, Hamburg, Germany (Bono) Department of Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile (Bonn) German Center for Neurodegenerative Diseases, Tubingen, Germany (Bonn) Center for Biomedical Ai, Hamburg, Germanyen
dc.description.addressC.F. Krebs, III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. E-mail: c.krebs@uke.de C.F. Krebs, Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany. E-mail: c.krebs@uke.de H.-W. Mittrucker, Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany. E-mail: h.mittruecker@uke.de H.-W. Mittrucker, University Medical Center Hamburg-Eppendorf, Institute for Immunology, Hamburg, Germany. E-mail: h.mittruecker@uke.deen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailKrebs C.F.; c.krebs@uke.de Mittrucker H.-W.; h.mittruecker@uke.deen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Collections:Articles
Show simple item record

Page view(s)

8
checked on Sep 7, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.